Mathers Edward T. - 08 Jun 2022 Form 3 Insider Report for Senti Biosciences, Inc.\ (SNTI)

Role
Director
Signature
/s/ Louis Citron, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
08 Jun 2022
Net transactions value
$0
Form type
3
Filing time
15 Jun 2022, 19:05:37 UTC
Previous filing
06 Jun 2022
Next filing
13 Jun 2022

No securities are beneficially owned.

Remarks:

Effective immediately following the Effective Time as defined in that certain Business Combination Agreement dated as of December 19, 2021, as amended, by and among Senti Sub I, Inc. (f/k/a Senti Biosciences, Inc.), Issuer (f/k/a Dynamics Special Purpose Corp.), and Explore Merger Sub, Inc., the reporting person was elected as a member of the board of directors of the Issuer.